Neuroanatomically precise, genome-wide maps of transcript distributions are critical resources
to complement genomic sequence data and to correlate functional and genetic brain …

Alzheimer disease (AD) and Parkinson disease (PD) are the most common neurodegenerative
disorders. For both diseases, early intervention is thought to be essential to the success …

Alzheimer's disease is the public health crisis of the 21st century. There is a clear need for a
widely available, inexpensive and reliable method to diagnosis Alzheimer's disease in the …

Objective: To test whether plasma tau is altered in Alzheimer disease (AD) and whether it is
related to changes in cognition, CSF biomarkers of AD pathology (including β-amyloid [Aβ] …

Availability of genome-scale in situ hybridization data allows systematic analysis of genetic
neuroanatomical architecture. Within the hippocampus, electrophysiology and lesion and …

Abstract Treatment of Alzheimer's disease (AD) is significantly hampered by the lack of easily
accessible biomarkers that can detect disease presence and predict disease risk reliably. …

Traumatic brain injury is a major health and socioeconomic problem that affects all societies.
However, traditional approaches to the classification of clinical severity are the subject of …

In many vertebrate and invertebrate cells, inositol 1,4,5-trisphospate production induces a
biphasic Ca2+ signal. Mobilization of Ca2+ from internal stores drives the initial burst. The …

Background Plasma tau phosphorylated at threonine 217 (p-tau217) and plasma tau
phosphorylated at threonine 181 (p-tau181) are associated with Alzheimer's disease tau pathology. …

Implementation of amyloid biomarkers in clinical practice would be accelerated if such
biomarkers could be measured in blood. We analyzed plasma levels of Aβ42 and Aβ40 in a …